Why MENA pharma investment is a risk-reward play

22 FEB 2022

Back to industry insights

In the MENA region, nascent manufacturing capabilities are laying attractive foundations for pharma investment. But, as Elena Ghose, Pharmaceuticals & Healthcare Analyst at Fitch Solutions explains, regulatory and pricing hurdles must be addressed

Topics

  • Medical
  • Investment
  • Healthcare

Industry Insights

View All

ArticleThe rise of UAE pharma manufacturing
Find Out More
ArticleWhy Dubai is a magnet for derma tourism
Find Out More
ArticleDubai and its regional pharma hub ambition
Find Out More